Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
another observation:
the first S-1 was registered 3/8 with a 3/7 pps at $2.35
the second S-1/A was registered 3/20 with a 3/17 pps of $2.05
final registration was for $1.25--a 47% reduction from 3/8 and a 39% from 3/20.
the dip has been to $1 from the $1.25 so a 20% pull back.
to compare, RXII did the same thing, several S-1's filed, around $2/pps, then the final PO at $.90 pps. the stock tanked 20% to $.72, rebounded on pumpy type news (news that really should not have effected the pps), dumped to $.60 then stabilized at the $.75 mark as it approaches catalysts in the next couple of months.
the thought was that RXII could not secure interest without giving a steep discount, maybe the same thing happened here; but the difference being that the CEO of RXII did not buy into the stock like TNDM's, and that RXII CEO has only been purchasing 10k portions on the open market on a trickle while he makes half a million in salary. note that TNDM's CEO purchased 4 year's salary at the $1.25 share offer; i would say that is a steep difference in the vote of confidence.
if there is a 33% pull back from the offer, i will have to ride it out, but i think 20% may be where this one settles, as that $2million dollar purchase by the CEO is an awful lot of sweetener to offset the bitter.
i am a novice trader, as everyday is a new day on the market.
ceo purchased the shares from the public offering. dilution involved hence the drop (3/23 offer: 3/28 close; 18mil shares at $1.25 and option for 2.5mil shares at public offering). once it stabilizes, i believe we will go up. compare against RGLS where the board members did not buy against a public offering. regardless, i am flipping between both depending on the direction of the wind. i just moved RGLS into TNDM for the $1-$1.05 range. only 5k shares. GL.
i hope he sells the thing as when i see their tech, it reminds me of TREO being purchased by Blackberry (that is my pipe dream vision, may not match reality). Treo was first in design, but outdated years later, blackberry bought them out regardless as compared to the blackberry, it was next level; then the touch screen came out from apple. oops. this one seems to be first in design, touch screen, and syncs with some sort of doctor network? plus the NIH funded program involving two other companies--makes me think if the program works, one of the other two will snatch up TNDM.
pipe dream speculation.
would this be similar to a deficit in capital gains? something that has a cap on it, but can be parlayed into the next tax season?
no, i wasn't. i was thinking about it in relation to the public offering lowered to $.90 when the pps at that time was double. searching online, i saw one website (small business.chron) and maybe investopedia, suggest that banks might not lend to a business with an accumulated deficit.
so you are saying that this could actually be a tax write off for an acquirer, an added perk? that is an interesting idea. $63 million in saved taxes? or would it be capped at a certain point with the balance kept rolling over the years?
but is it tracked by institutional investors for these public offerings?
if so, how does it figure in?
10q
"Since inception, we have incurred significant losses. Substantially all of our losses to date have resulted from research and development expenses in connection with our clinical and research programs and from general administrative costs. At September 30, 2016, we had an accumulated deficit of $63.8 million. We expect to continue to incur significant losses for the foreseeable future, particularly as we advance our development programs for RXI-109 and Samcyproneâ„¢."
it is listed under liabilities and stockholders' equity
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 authorized; no shares issued or outstanding
— —
Common stock, $0.0001 par value, 100,000,000 shares authorized; 6,599,846 and 6,534,846 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively
Sep 2016.........Dec 2015
66,795.............65,994-------Additional paid-in capital
(63,760).........(57,105)-------Accumulated deficit
3,036.................8,890-------Total stockholders’ equity
accumulated deficit = $63 million
is this from the decline in shareholder's value due to the splits and dilution?
what is it from?
reverse split pps first would be nice.
what do you mean by maintenance odd equipment deal in relation to a collaboration?
i am dumb that way.
any idea as to the new burn rate?
RXII now has a new department--cancer--with several doctor's salaries and administrative as well as whatever their clinical trials will cost.
there is only one way to find out, and i hope that i am wrong but i have become jaded by these things not specific to this particular company. phrasing can be misleading, especially from upper management in PR's. i hope you and the others here are right. GL.
if these are new "new" results, shouldn't the powers that be say that they will be announcing updates for the latest results? they had the interim peek, then they will have the end of trial. is this the end of the trial?
yes i did see that, and that can be interpreted two ways. so i guess it is off to i.r. to see what they mean.
what if they just present the same data as from november?
it is 2/16--what happened? did the tweet live up to the presentation?
it came up on my oncs email filing alert yesterday, and the form was dated 12/31/16.
thanks to all for responding, that explains it.
what's the deal with the ridgeback 13g/a?
potential dilution from class A over the course of the changes to the offering:
11/10
3,025,500
11/29
2,130,150
12/14
2,696,600
based on the phrasing, i don't know how to calculate the class B into the equation
this is what i see in the alterations.
it may be wrong, i am a novice.
i edited out the $.0001 portion, maybe i edited out too much???
**********************
11/10
pps: $1.19 as of 11/10
2,017,000 Class A Units, with each Class A Unit consisting of one share of common stock and a warrant to purchase half of one share of our common stock
9,600 Class B Units. Each Class B Unit will consist of one share of Series B Convertible Preferred Stock, convertible into 840 shares of common stock and warrants to purchase 420 shares of our common stock
11/29
pps: $1.69 as of 11/28
1,420,100 Class A Units, with each Class A Unit consisting of one share of common stock and a warrant to purchase half of one share of our common stock
9,600 Class B Units. Each Class B Unit will consist of warrants to purchase 295.5 shares of our common stock and one share of Series B Convertible Preferred Stock, convertible into 591 shares of common stock
12/14
pps: $1.78 as of 12/9
1,348,300 Class A Units, with each Class A Unit consisting of one share of common stock, and a warrant to purchase one share of our common stock
9,600 Class B Units. Each Class B Unit will consist of warrants to purchase 561 shares of our common stock and one share of Series B Convertible Preferred Stock, convertible into 561 shares of common stock
**********************
isn't the 12/14 offer less dilution than the 11/10?
don't know what the deal is with stock twits.
so the current pps is $1.78, much better, but they have not yet finalized the offering--no offering price for the series a and b.
is it going to happen after tomorrow?
does this mean they will add more color?
good luck to all longs.
live long and prosper.
dec 9th. $1.78. nice! well see how it plays. christmas time i always find to dip on low volume (pharma stocks in general that are in penny land--yes, this is penny land), but maybe this is a different kind of christmas. maybe this is the one where it goes up?
they better have some sort of presentation tomorrow--is that the proxy thing? i dunno.
i am an idiot.
stupid stupid stupid.
also, they have that offering looming out there. the last posting was at $1.69.
if they wanted to beef up the pps prior to issuing shares, they should have done something more substantial with their update.
maybe more color will be added at this upcoming proxy vote?
the upcoming proxy vote--they better have a webinar and q&a because that pr was lightweight, it lacked substance: no photos of scar regression, no figures or numbers, no details, and at least the scarring was supposed to be a midpoint so it should have been on its own pr. all this wait time and it had the appearance as if some one typed out a memo in the last minute as they were hurrying out the door to go on vacation.
not what i expected as far as an update, i thought it would be like the 3 month reveal.
thanks titan
maxim and rodman & renshaw--have they ever asked questions at a quarterly prior to this one?
i don't recall seeing them before. is this new interest?
yes. it looks very strange. i have seen this before and i am always wary, but there is news pending so that is the rub. stock twits is rife with day traders, especially the chartists looking for the right candlestick so i am aware this is on their radar big time. speaking of which, on the 9 million day, that candle stick had a long tail at the top which to me suggests heavy shorting at that point, or would that be the day traders selling? i dunno. it is weird.
it reminds me of dr leo martin's book, "baby steps";
the chart is forming baby steps to higher highs.
i don't understand why people call this a pump and dump when there are two reveals pending in the next few weeks.
if u want to read the adis thing, follow the google link you posted.
next to each of the reads in that list has an upside down triangle.
click on that, then click cached.
some of the time, the entire article will unfold before your eyes, and this
is one of those instances.
click on "cached" in the drop down arrow
i think they have it wrong on the stocktwits board in regards to the filings.
i think rxii is just putting these out there as the pps fluctuates to get the best offering price possible.
it stepped up, hopefully it does not step down. they will probably file another one if this stays above $1.69 long enough, or after the release of data. just my opinion. i suck at this.
why do you say that?
was there a tweet?
an email?
hypothetically speaking, let's say they did know the results and filed the s1a on 11/29 knowing that the results were bad and wanted to solidify as high a pps as possible--wouldn't that be insider knowledge? they would not be able to do that, right? am i wrong on that?
all hypothetical. again, i think they are just setting up in case of a worst case scenario, you saw the 3 month, i think this is in the bag as long as we see improvement beyond those photos.
biopharma. i saw that. i did not see a filing at first so i was dismissive of the stock twit post. whatever that guy received in his email is the same prospectus filed 11/29 to the sec.
the prospectus is exactly the same as the one filed 11/10 except that:
1) 11/10 the pps was marked at $1.19
2) 11/29 the pps was marked at $1.69
so what they are doing is getting this on record in case they want to initiate the filing, it does not mean it will be filed as is.
if results come out positive, then i am sure they will revise it once again and then run with it, if negative, then they have the $1.69 pps instead of the $1.19.
i think all they are doing is covering their bases, this is my interpretation and could be wrong.
i saw that.
i wrote IR to see what days they have off for the holidays.
i will post if they respond, but i bet we will see some press releases during the next two weeks as anything during the weeks of christmas and new year's will mean many mm's on leave.
apparently not.
11.29.16 slide show investor presentation posted
http://www.snl.com/Cache/c36908626.html
is this a hammer on the chart?
red, so less bullish; but hey, i think the worm has turned.
regarding the offering and those on stocktwits...
keep in mind that arry had the same thing going in october, and as soon as results hit, they initiated the offering--for a whopping $100mi+.
now, look at their chart.
i have high hopes on this one, so i am biased, heavily. but if rxii is delaying the offering, then they have high hopes as well.
GLTA